Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > One good decision TH could make right away

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Mar 29, 2022 6:41am

57 Views

Post# 34554426

RE:RE:RE:RE:RE:RE:One good decision TH could make right away

SPECEO isspecial. His posts are very oriented, and often misleading . They are interesting to read however. When he announces some good news in perspective try to sell a part of your shares if you can.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program